Polymyxin b

Polymyxin B for Injection USP

50 MG / VIAL Powder For SolutionCanadaNot marketedAuthorised 3 May 2012

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Polymyxin b

Polymyxin B for Injection USP

50 MG / VIAL Powder For SolutionCanadaNot marketedAuthorised 3 May 2012

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Polymyxin b
Strength: 50 MG / VIAL
Dosage form: Powder For Solution
Route: Intramuscular, Intrathecal, Intravenous, Ophthalmic
Register: Canada (Health Canada)
Status: Not marketed
Status in the register: Dormant
Authorised: 3 May 2012
Registration: DIN 02375893
Marketing authorisation holder: Sterimax INC
ATC code: J01XB02
Group: Anti-infectives for systemic use
Supply: PRESCRIPTION